NCT00747123 2024-10-03A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple MyelomaCelgenePhase 2 Completed30 enrolled 15 charts
NCT01712308 2023-10-10Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or AnemiaM.D. Anderson Cancer CenterPhase 2 Completed56 enrolled 9 charts
NCT01736683 2022-10-24Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)Merck Sharp & Dohme LLCPhase 2 Completed74 enrolled 33 charts